Advertisement
Advertisement

WINT

WINT logo

Windtree Therapeutics Inc

0.22
USD
-0.0069
-3.04%
Jan 17, 15:19 UTC -5
Closed
...

Windtree Therapeutics Inc Profile

About

Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.

Info & Links

CEO

Craig E. Fraser

Headquarters

2600 KELLY ROAD, SUITE 100
WARRINGTON, PA 18976, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

https://windtreetx.com

Auditor

EisnerAmper LLP

Share holders

38

Employees

15

Windtree Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

1.98M

Enterprise Value

785.80K

Enterprise Value/EBITDA(ttm)

-0.03

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.51

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-362.76%

Return on Invested Capital(ttm)

-368.24%

Return on Assets(ttm)

-79.65%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-25.38M

Net Income Available to Common(ttm)

-10.71M

Diluted EPS(ttm)

-16.47

Share Statistics

Beta (5Y Monthly)

0.57

52-Week Change

-98.79%

S&P 500 52-Week Change

23.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

8.99M

Dividend Yield

0.00%

Float4

11.01M

% Held by Insiders

0.33%

% Held by Institutions

29.33%

Balance Sheet

Total Cash(mrq)

2.30M

Total Cash Per Share(mrq)

0.26

Total Debt(mrq)

1.11M

Total Debt/Equity(mrq)

25.13%

Current Ratio(mrq)

0.27%

Quick Ratio(mrq)

0.27%

Book Value Per Share(mrq)

1.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-13.21

Free Cash Flow(ytd)

-11.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement